Inflazyme Pharmaceuticals Ltd.
TSX : IZP

Inflazyme Pharmaceuticals Ltd.

June 01, 2006 15:10 ET

Inflazyme to Present at Pacific Growth Equities' Life Sciences Growth Conference

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - June 1, 2006) - Inflazyme Pharmaceuticals Ltd. (TSX:IZP) announced today that it will present at Pacific Growth Equities' Life Sciences Growth Conference on Tuesday, June 13, 2006 at 10:00 a.m. at the InterContinental Mark Hopkins Hotel in San Francisco. Dr. Kevin Mullane, President and CEO of Inflazyme, will provide a business overview and discuss the Company's product pipeline.

Inflazyme Pharmaceuticals is a biopharmaceutical company pioneering medical breakthroughs to transform the lives of patients with respiratory and inflammatory diseases worldwide. Further information on the Company may be obtained from its website at www.inflazyme.com.

Statements in this news release other than historical information are forward-looking statements subject to risks and uncertainties. Actual results could differ materially depending on factors such as the availability of resources, the timing and effects of regulatory actions, the strength of competition, the outcome of litigation and the effectiveness of patent protection. Additional information regarding risks and uncertainties is set forth in the current Annual Information Form for Inflazyme on file with the Canadian Securities Commissions. The Toronto Stock Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this information.

The Toronto Stock Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this information.

Contact Information

  • Inflazyme Pharmaceuticals Ltd.
    Julie Rezler
    Sr. Director, Corporate Development
    Toll Free: 1-800-315-3660 or (604) 279-8511
    (604) 279-8711 (FAX)
    ir@inflazyme.com
    www.inflazyme.com